ALNOV.PA • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALNOV.PA in your mock portfolio yet.
The company is currently loss-making, as indicated by its negative EPS and PE ratio. This suggests that Novacyt S.A. has not yet restored sustainable profitability after prior revenue declines post-COVID testing boom. Without clear evidence of a turnaround in earnings, the financial profile remains weak from an equity investor’s perspective.
The stock is trading at €0.40, below its 200-day moving average of €0.47, pointing to a prevailing downtrend. The recent 4.3% decline over the last month and an RSI of 37.93 suggest weak momentum with only mild signs of approaching oversold territory rather than a clear reversal setup.
Alternative data for Novacyt S.A. is mixed: web traffic is modest, hiring has ticked up from a low base, and social media engagement is broadly flat with only slight growth on some platforms. These signals do not yet point to a strong inflection in commercial traction or investor interest, but they also do not indicate a sharp deterioration.
Overall, Novacyt S.A. currently presents a bearish setup, driven by ongoing losses, a stock price below its long-term moving average, and weak recent price momentum. Alternative data are broadly neutral and do not yet provide a strong counter-signal to the negative financial and technical picture. Until there is clearer evidence of earnings recovery or a decisive technical reversal, the risk-reward profile appears skewed to the downside.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: